Orange Book product · Brand (NDA)
TOFRANIL
IMIPRAMINE HYDROCHLORIDE
At a glance
Approved Prior to Jan 1, 1982
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
IMIPRAMINE HYDROCHLORIDE
Strength
12.5MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
NDA 011838
Product number
002
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- —JANIMINEBrand (NDA)
NDA 017895 · ABBOTT
- —PRESAMINEBrand (NDA)
NDA 011836 · SANOFI AVENTIS US
- 2012IMIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 040903 · LEADING
- 2010IMIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 090441 · CHARTWELL
- 2008IMIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 040751 · OXFORD PHARMS
- 1990IMIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 081048 · SUN PHARM INDUSTRIES
- 1990IMIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 081049 · SUN PHARM INDUSTRIES
- 1990IMIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 081050 · SUN PHARM INDUSTRIES
- 1987IMIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 089422 · PAR PHARM
- 1987IMIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 089497 · PAR PHARM
- 1984IMIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 087846 · SPECGX LLC
- 1983IMIPRAMINE HYDROCHLORIDEGeneric (ANDA)
ANDA 088292 · STRIDES PHARMA INTL
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
